Derivation and validation of urinary TIMP-1 for the prediction of acute kidney injury and mortality in critically ill children.
Derivation and validation of urinary TIMP-1 for the prediction of acute kidney injury and mortality in critically ill children.
复制标题
DOI:
10.1186/s12967-022-03302-0
复制
发表时间:
2022-02-23
影响因子:
7.4
通讯作者:
Li Y
中科院分区:
文献类型:
--
作者:
Huang H;Lin Q;Dai X;Chen J;Bai Z;Li X;Fang F;Li Y
Acute kidney injury (AKI) is associated with high morbidity and mortality. Multiple urinary biomarkers have been identified to be associated with the prediction of AKI and outcomes. However, the accuracy of these urinary biomarkers for AKI and associated outcomes has not been clearly defined, especially in heterogeneous populations. The aims of the study were to compare the ability of 10 existing or potential urinary biomarkers to predict AKI and pediatric intensive care unit (PICU) mortality and validate urinary tissue inhibitor of metalloproteinases-1 (uTIMP-1) as a better biomarker for early prediction in heterogeneous critically ill children. A derivation-validation approach with separate critically ill cohorts was designed. We first conducted a prospective cohort study to determine the ability of 10 urinary biomarkers serially measured in 123 children during the first 7 days of PICU stay to predict AKI and PICU mortality (derivation study) and further validated the better biomarker of uTIMP-1 in a separate cohort of 357 critically ill children (validation study). AKI diagnosis was based on KDIGO classification with serum creatinine and urine output. PICU mortality was defined as all-cause mortality. In the derivation cohort, 17 of 123 (13.8%) children developed AKI stage 3 or died during the PICU stay, and both the initial and peak uTIMP-1 displayed the highest AUCs of 0.87 (0.79–0.94) and 0.90 (0.84–0.96), respectively, for predicting AKI stage 3 or death. In the validation cohort, 78 of 357 (21.8%) developed AKI during the first week after admission, and 38 (10.6%) died during the PICU stay. The initial uTIMP-1 level was validated to be independently associated with AKI (AOR = 2.88, 95% CI 1.97–4.21), severe AKI (AOR = 2.62, 95% CI 1.78–3.88), AKI stage 3 (AOR = 2.94, 95% CI 1.84–4.68) and PICU mortality (AOR = 1.92, 95% CI 1.11–3.30) after adjustment for potential confounders. The predictive values of uTIMP-1 for AKI, severe AKI, AKI stage 3 and PICU mortality were 0.80 (0.74–0.86), 0.83 (0.77–0.89), 0.84 (0.77–0.92) and 0.83 (0.76–0.89), respectively. Urinary TIMP-1 levels have been identified and validated to be independently associated with AKI and PICU mortality in independent prospective cohorts and may be an early potential indicator of AKI and PICU mortality in critically ill children. The online version contains supplementary material available at 10.1186/s12967-022-03302-0.
登录
查看更多内容
DOI:
10.1056/nejmoa1611391
发表时间:
2017-01-05
期刊:
The New England journal of medicine
影响因子:
--
作者:
Kaddourah A;Basu RK;Bagshaw SM;Goldstein SL;AWARE Investigators
通讯作者:
AWARE Investigators
影响因子:
3.6
作者:
Kuai, Yuxian;Huang, Hui;Li, Yanhong
通讯作者:
Li, Yanhong
影响因子:
4.3
作者:
Erez, Daniella Levy;Denburg, Michelle R.;Sullivan, Kathleen E.
通讯作者:
Sullivan, Kathleen E.
DOI:
10.1080/15287394.2017.1299655
发表时间:
2017-01-01
影响因子:
2.6
作者:
Kim, Kyeong Seok;Yang, Hun Yong;Kim, Hyung Sik
通讯作者:
Kim, Hyung Sik
影响因子:
6.7
作者:
George B;Wen X;Mercke N;Gomez M;O'Bryant C;Bowles DW;Hu Y;Hogan SL;Joy MS;Aleksunes LM
通讯作者:
Aleksunes LM